3-170467145-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_020949.3(SLC7A14):c.2226G>A(p.Arg742=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00567 in 1,614,250 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 37 hom. )
Consequence
SLC7A14
NM_020949.3 synonymous
NM_020949.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.60
Genes affected
SLC7A14 (HGNC:29326): (solute carrier family 7 member 14) This gene is predicted to encode a glycosylated, cationic amino acid transporter protein with 14 transmembrane domains. This gene is primarily expressed in skin fibroblasts, neural tissue, and primary endothelial cells and its protein is predicted to mediate lysosomal uptake of cationic amino acids. Mutations in this gene are associated with autosomal recessive retinitis pigmentosa. In mice, this gene is expressed in the photoreceptor layer of the retina where its expression increases over the course of retinal development and persists in the mature retina. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 3-170467145-C-T is Benign according to our data. Variant chr3-170467145-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 780032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-170467145-C-T is described in Lovd as [Benign]. Variant chr3-170467145-C-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC7A14 | NM_020949.3 | c.2226G>A | p.Arg742= | synonymous_variant | 8/8 | ENST00000231706.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC7A14 | ENST00000231706.6 | c.2226G>A | p.Arg742= | synonymous_variant | 8/8 | 2 | NM_020949.3 | P1 | |
SLC7A14-AS1 | ENST00000643719.1 | n.273+6733C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00551 AC: 839AN: 152244Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
839
AN:
152244
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00586 AC: 1472AN: 251372Hom.: 10 AF XY: 0.00578 AC XY: 785AN XY: 135848
GnomAD3 exomes
AF:
AC:
1472
AN:
251372
Hom.:
AF XY:
AC XY:
785
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00569 AC: 8318AN: 1461888Hom.: 37 Cov.: 31 AF XY: 0.00572 AC XY: 4160AN XY: 727244
GnomAD4 exome
AF:
AC:
8318
AN:
1461888
Hom.:
Cov.:
31
AF XY:
AC XY:
4160
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00551 AC: 840AN: 152362Hom.: 3 Cov.: 32 AF XY: 0.00581 AC XY: 433AN XY: 74504
GnomAD4 genome
AF:
AC:
840
AN:
152362
Hom.:
Cov.:
32
AF XY:
AC XY:
433
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | SLC7A14: BP4, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at